NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of Humacyte, Inc. ("Humacyte" or the "Company") (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, inclusive. For more information, submit a form at Humacyte, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (2 ...